Product
UB-621
2 clinical trials
2 indications
Indication
Genital HerpesIndication
Herpes, GenitalClinical trial
A Randomized, Single-blind, Placebo-control, Parallel, Phase II Trial to Evaluate the Safety and Efficacy of UB-621 in Adults With Recurrent Genital HSV-2 InfectionStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Two-Stage, Randomized, Double-Blind, Dose-Ranging, Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621 on HSV Shedding in Adults With Recurrent Genital HSV-2 Infection.Status: Not yet recruiting, Estimated PCD: 2024-06-30